{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:12:25Z","timestamp":1792239145976,"version":"4.4.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:p>Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome secondary to germline fumarate hydratase (<jats:italic toggle=\"yes\">FH<\/jats:italic>) mutation presents with cutaneous and uterine leiomyomas, and a distinctive aggressive renal carcinoma. Identification of HLRCC patients presenting first with uterine leiomyomas may allow early intervention for renal carcinoma. We reviewed the morphology and immunohistochemical (IHC) findings in patients with uterine leiomyomas and confirmed or presumed HLRCC. IHC was also performed on a tissue microarray of unselected uterine leiomyomas and leiomyosarcomas. FH-deficient leiomyomas underwent Sanger and massively parallel sequencing on formalin-fixed paraffin-embedded tissue. All 5 patients with HLRCC had at least 1 FH-deficient leiomyoma: defined as completely negative FH staining with positive internal controls. One percent (12\/1152) of unselected uterine leiomyomas but 0 of 88 leiomyosarcomas were FH deficient. FH-deficient leiomyoma patients were younger (42.7 vs. 48.8 y, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.024) and commonly demonstrated a distinctive hemangiopericytomatous vasculature. Other features reported to be associated with FH-deficient leiomyomas (hypercellularity, nuclear atypia, inclusion-like nucleoli, stromal edema) were inconstantly present. Somatic FH mutations were identified in 6 of 10 informative unselected FH-deficient leiomyomas. None of these mutations were found in the germline. We conclude that, while the great majority of patients with HLRCC will have FH-deficient leiomyomas, 1% of all uterine leiomyomas are FH deficient usually due to somatic inactivation. Although IHC screening for FH may have a role in confirming patients at high risk for hereditary disease before genetic testing, prospective identification of FH-deficient leiomyomas is of limited clinical benefit in screening unselected patients because of the relatively high incidence of somatic mutations.<\/jats:p>","DOI":"10.1097\/pas.0000000000000573","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T12:52:48Z","timestamp":1447764768000},"page":"599-607","source":"Crossref","is-referenced-by-count":137,"title":["Fumarate Hydratase\u2013deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings"],"prefix":"10.1097","volume":"40","author":[{"given":"Wesley J.","family":"Harrison","sequence":"first","affiliation":[{"name":"University of Sydney"},{"name":"Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Andrici","sequence":"additional","affiliation":[{"name":"University of Sydney"},{"name":"Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Maclean","sequence":"additional","affiliation":[{"name":"Douglass Hanly Moir Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raha","family":"Madadi-Ghahan","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Farzin","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"Sioson","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Toon","sequence":"additional","affiliation":[{"name":"University of Sydney"},{"name":"Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research"},{"name":"Histopath Pathology, North Ryde"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Clarkson","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Watson","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Pickett","sequence":"additional","affiliation":[{"name":"Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Field","sequence":"additional","affiliation":[{"name":"Familial Cancer Clinic, Royal North Shore Hospital, St Leonards"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Crook","sequence":"additional","affiliation":[{"name":"Familial Cancer Clinic, Royal North Shore Hospital, St Leonards"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Tucker","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Hereditary Cancer Clinic, Prince of Wales Hospital, Randwick"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Goodwin","sequence":"additional","affiliation":[{"name":"University of Sydney"},{"name":"Department of Medical Oncology, Concord Hospital, Concord West"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndal","family":"Anderson","sequence":"additional","affiliation":[{"name":"University of Sydney"},{"name":"Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuvana","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Mater Hospital, South Brisbane, Qld, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Grossmann","sequence":"additional","affiliation":[{"name":"\u0160ikl\u2019s Department of Pathology, University Hospital, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Martinek","sequence":"additional","affiliation":[{"name":"\u0160ikl\u2019s Department of Pathology, University Hospital, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Ondi\u010d","sequence":"additional","affiliation":[{"name":"\u0160ikl\u2019s Department of Pathology, University Hospital, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ond\u0159ej","family":"Hes","sequence":"additional","affiliation":[{"name":"\u0160ikl\u2019s Department of Pathology, University Hospital, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiril","family":"Trpkov","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Calgary Laboratory Services, University of Calgary, Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick J.","family":"Clifton-Bligh","sequence":"additional","affiliation":[{"name":"University of Sydney"},{"name":"Cancer Genetics, Hormones and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Dwight","sequence":"additional","affiliation":[{"name":"University of Sydney"},{"name":"Cancer Genetics, Hormones and Cancer Group, Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Gill","sequence":"additional","affiliation":[{"name":"University of Sydney"},{"name":"Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research"},{"name":"Department of Anatomical Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2340\/0001555553409416","article-title":"Cutaneous leiomyomata with uterine leiomyomata","volume":"53","author":"Reed","year":"1973","journal-title":"Acta Derm Venereol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","article-title":"Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency","volume":"12","author":"Alam","year":"2003","journal-title":"Hum Mol Genet"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PAS.0b013e31825ec16f","article-title":"Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome","volume":"37","author":"Sanz-Ortega","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00428-015-1783-y","article-title":"Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC)","volume":"467","author":"Martinek","year":"2015","journal-title":"Virchows Arch"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ogc.2005.12.004","article-title":"Epidemiology of myomas","volume":"33","author":"Payson","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PGP.0000000000000091","article-title":"Current morphologic criteria perform poorly in identifying hereditary leiomyomatosis and renal cell carcinoma syndrome-associated uterine leiomyomas","volume":"33","author":"Alsolami","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/modpathol.2013.215","article-title":"Uterine smooth muscle tumors with features suggesting fumarate hydratase aberration: detailed morphologic analysis and correlation with S-(2-succino)-cysteine immunohistochemistry","volume":"27","author":"Reyes","year":"2014","journal-title":"Mod Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J Pathol"},{"key":"R14-20230922","first-page":"263A","article-title":"IHC screening of unclassified RCC detects tumors associated with HLRCC","volume":"28","author":"Trpkov","year":"2015","journal-title":"Mod Pathol"},{"key":"R15-20230922","first-page":"271","article-title":"Hereditary leiomyomatosis and renal cell carcinoma (HLRCC)-associated renal cancer: a comparison of fumarate hydratase (FH) and S-(2-succino)-cysteine (2SC) immunohistochemistry as ancillary tools","volume":"28","author":"Chen","year":"2015","journal-title":"Mod Pathol"},{"key":"R16-20230922","first-page":"276A","article-title":"Leiomyoma with bizarre nuclei: correlation between morphology and fumarate\/S-(2-succino)-cysteine expression","volume":"28","author":"Bennett","year":"2015","journal-title":"Mod Pathol"},{"key":"R17-20230922","first-page":"117A","article-title":"Immunohistochemistry for 2SC and FH in cutaneous leiomyomas may aid in identification of patients with HLRCC (hereditary leiomyomatosis and renal cell carcinoma syndrome)","volume":"28","author":"Buelow","year":"2015","journal-title":"Mod Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAT.0b013e3283539932","article-title":"Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia","volume":"44","author":"Gill","year":"2012","journal-title":"Pathology"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canlet.2005.04.017","article-title":"No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas","volume":"235","author":"Barker","year":"2006","journal-title":"Cancer Lett"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/sj.bjc.6600502","article-title":"Low frequency of somatic mutations in the FH\/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas","volume":"87","author":"Barker","year":"2002","journal-title":"Br J Cancer"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9440(10)63091-X","article-title":"Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors","volume":"164","author":"Lehtonen","year":"2004","journal-title":"Am J Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ijc.21798","article-title":"Analysis of fumarate hydratase mutations in a population-based series of early onset uterine leiomyosarcoma patients","volume":"119","author":"Ylisaukko-oja","year":"2006","journal-title":"Int J Cancer"},{"key":"R23-20230922","first-page":"4554","article-title":"Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families","volume":"62","author":"Kiuru","year":"2002","journal-title":"Cancer Res"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2133.2005.06678.x","article-title":"Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer","volume":"153","author":"Alam","year":"2005","journal-title":"Br J Dermatol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201605000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:22:50Z","timestamp":1695421370000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201605000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000573","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}